DarioHealth Corp. (DRIO)
Stock Price Chart
Key Info
| Market Cap | 61.83M |
| Revenue (ttm) | 6.98M |
| Net Income (ttm) | -20.88M |
| Shares Out | 7.21M |
| EPS (ttm) | -10.35 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 13, 2020 |
| Last Price | $16.30 |
| Previous Close | $14.70 |
| Change ($) | 1.60 |
| Change (%) | 10.88% |
| Day's Open | 15.48 |
| Day's Range | 15.00 - 16.65 |
| Day's Volume | 191,523 |
| 52-Week Range | 3.02 - 18.84 |
More Stats
| Market Cap | 61.83M |
| Enterprise Value | 49.08M |
| Earnings Date (est) | Nov 17, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 7.21M |
| Float | 2.82M |
| EPS (basic) | -5.85 |
| EPS (diluted) | -10.35 |
| FCF / Share | -3.27 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 6,415 |
| Short Ratio | 0.07 |
| Short % of Float | 0.36% |
| Beta | 0.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 8.85 |
| PB Ratio | 4.42 |
| Revenue | 6.98M |
| Operating Income | -21.22M |
| Net Income | -20.88M |
| Free Cash Flow | -13.49M |
| Net Cash | 12.75M |
| Net Cash / Share | 3.36 |
| Gross Margin | 37.18% |
| Operating Margin | -303.79% |
| Profit Margin | -366.50% |
| FCF Margin | -193.10% |
| ROA | -89.20% |
| ROE | -230.70% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.56 | 7.39 | 5.17 | 2.80 | 0.82 | 0.05 | - | - |
| Revenue Growth | 2.23% | 43.02% | 84.45% | 240.58% | 1513.73% | - | - | - |
| Gross Profit | 2.60 | 1.77 | 1.31 | -0.83 | -0.86 | -2.71 | - | - |
| Operating Income | -17.71 | -17.69 | -14.42 | -11.10 | -7.70 | -11.36 | -13.56 | -3.97 |
| Net Income | -17.74 | -17.80 | -15.74 | -10.90 | -7.14 | -12.88 | -13.93 | -5.69 |
| Shares Outstanding | 2.27 | 1.17 | 0.48 | 0.26 | 0.09 | 0.02 | 0.01 | 0.01 |
| Earnings Per Share | -8.00 | -15.63 | -32.80 | -41.80 | -76.80 | -666.00 | -1,367.89 | -827.93 |
| Operating Cash Flow | -15.73 | -11.47 | -10.62 | -8.38 | -6.28 | -8.58 | -7.60 | -2.98 |
| Capital Expenditures | -0.10 | -0.07 | -0.20 | -0.81 | -0.11 | -0.56 | -1.40 | -0.53 |
| Free Cash Flow | -15.82 | -11.54 | -10.81 | -9.19 | -6.39 | -9.14 | -9.00 | -3.52 |
| Cash & Equivalents | 20.59 | 11.22 | 3.98 | 1.32 | 2.75 | 1.54 | 2.46 | 1.27 |
| Total Debt | 0.77 | - | - | - | - | - | - | - |
| Net Cash / Debt | 19.81 | 11.22 | 3.98 | 1.32 | 2.75 | 1.54 | 2.46 | 1.27 |
| Assets | 24.57 | 14.09 | 6.96 | 3.87 | 5.08 | 3.08 | 4.12 | 2.32 |
| Liabilities | 5.68 | 5.16 | 3.02 | 10.41 | 6.66 | 8.38 | 4.20 | 3.38 |
| Book Value | 18.89 | 8.93 | 3.94 | -6.54 | -1.58 | -5.30 | -0.09 | -1.07 |
Company Profile
Company Details
| Full Name | DarioHealth Corp. |
| Country | Israel |
| Employees | 62 |
| CEO | Erez Raphael |
Stock Information
| Ticker Symbol | DRIO |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Unique Identifier | NASDAQ: DRIO |
Description
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.